- Next-Generation Sequencing solutions of ThermoFisher Scientific help identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients Thermo Fisher Scientific, the world leader in serving science, received breakthrough device designation for its Oncomine Precision Assay by the U.S. Food and Drug Administration (FDA). The assay can be
